Results
1 -
10 of
57Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction, European Journal of Clinical Pharmacology Cyclooxygenase enzymes in human vascular disease, Selective COX-2 Inhibitors Bleeding time and antiplatelet agents in normal volunteers, International Journal of Clinical and Laboratory Research Transfusion and Thromboembolic Prophylaxis, Anaesthesia, Pain, Intensive Care and Emergency Medicine u2014 A.P.I.C.E. REVERSIBLE INHIBITION OF PLATELET FUNCTION WITH INDOBUFEN, InPharma In vitro and ex vivo effects of indobufen on red blood cell deformability, European Journal of Clinical Pharmacology Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man, European Journal of Clinical Pharmacology Indobufen (K 3920), a new inhibitor of platelet aggregation: Effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man, European Journal of Clinical Pharmacology Indobufen Prevents Platelet Aggregation in Open Trial, InPharma INDOBUFEN: in cerebrovascular disease, InPharma